Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
出版年份 2021 全文链接
标题
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-09
DOI
10.1038/s41467-021-21177-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
- (2020) Nina Shah et al. LEUKEMIA
- Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.
- (2020) Nikhil C. Munshi et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Cereblon genetic changes associate with acquired resistance to Lenalidomide or Pomalidomide in Multiple Myeloma
- (2020) Sarah Gooding et al. BLOOD
- Genome instability in multiple myeloma
- (2020) Carl Jannes Neuse et al. LEUKEMIA
- Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B cell malignancies
- (2020) Jordan Gauthier et al. BLOOD
- Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
- (2020) Nirav N. Shah et al. NATURE MEDICINE
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- Deciphering the chronology of copy number alterations in Multiple Myeloma
- (2019) Anil Aktas Samur et al. Blood Cancer Journal
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
- (2019) Mattia D’Agostino et al. LEUKEMIA
- Genomic landscape and chronological reconstruction of driver events in multiple myeloma
- (2019) Francesco Maura et al. Nature Communications
- Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies
- (2019) Jiali Cheng et al. Frontiers in Oncology
- CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones
- (2018) Sören Müller et al. BIOINFORMATICS
- Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
- (2018) Brian A. Walker et al. BLOOD
- Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14)
- (2018) Alice Cleynen et al. BLOOD
- Genomics of Multiple Myeloma
- (2017) Sebastien Robiou du Pont et al. JOURNAL OF CLINICAL ONCOLOGY
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- (2017) L. Rasche et al. Nature Communications
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
- (2016) Ronglai Shen et al. NUCLEIC ACIDS RESEARCH
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started